Bereich
Infektiologie | Infektionsprävention | Reisemedizin
INFEKT · Dept. I
Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study
van Sighem A, Low N, Fraser C, Bezemer D, Jeannin A, Derendinger S, de Wolf F, Gebhardt M, Vernazza P, Bucher H, Glass T, Vidondo B, Swiss HIV Cohort Study. Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. PloS one 2012; 7:e44819.
14.09.2012Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study
14.09.2012PloS one 2012; 7:e44819
van Sighem Ard, Low Nicola, Fraser Christophe, Bezemer Daniela, Jeannin Andre, Derendinger Steven, de Wolf Frank, Gebhardt Martin, Vernazza Pietro, Bucher Heiner C, Glass Tracy R, Vidondo Beatriz, Swiss HIV Cohort Study
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study
Wang Q, Fux C, Bucher H, Stoeckle M, Furrer H, Weber R, Hirschel B, Vernazza P, Cavassini M, Bernasconi E, Young J, Swiss HIV Cohort Study. The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antivir Ther (Lond) 2012; 18:337-44.
12.09.2012The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study
12.09.2012Antivir Ther (Lond) 2012; 18:337-44
Wang Qing, Fux Christoph, Bucher Heiner C, Stoeckle Marcel, Furrer Hansjakob, Weber Rainer, Hirschel Bernard, Vernazza Pietro, Cavassini Matthias, Bernasconi Enos, Young Jim, Swiss HIV Cohort Study
Determinants of hepatitis a vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland
Crisinel P, Posfay-Barbe K, Aebi C, Cheseaux J, Kahlert C, Rudin C, Nadal D, Siegrist C, Swiss Mother and Child HIV Cohort Study of Switzerland (MoCHiV). Determinants of hepatitis a vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland. Clin Vaccine Immunol 2012; 19:1751-7.
29.08.2012Determinants of hepatitis a vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland
29.08.2012Clin Vaccine Immunol 2012; 19:1751-7
Crisinel Pierre Alex, Posfay-Barbe Klara Maria, Aebi Christoph, Cheseaux Jean-Jacques, Kahlert Christian, Rudin Christoph, Nadal David, Siegrist Claire-Anne, Swiss Mother and Child HIV Cohort Study of Switzerland (MoCHiV)
Salmonella aortitis treated with endovascular aortic repair: a case report
Strahm C, Lederer H, Schwarz E, Bachli E. Salmonella aortitis treated with endovascular aortic repair: a case report. J Med Case Rep 2012; 6:243.
15.08.2012Salmonella aortitis treated with endovascular aortic repair: a case report
15.08.2012J Med Case Rep 2012; 6:243
Strahm Carol, Lederer Heidi, Schwarz Esther I, Bachli Esther B
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic
Wandeler G, Rauch A, Furrer H, Bernasconi E, Stöckle M, Calmy A, Clerc O, Günthard H, Bregenzer A, Gsponer T, Swiss HIV Cohort Study. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis 2012; 55:1408-16.
14.08.2012Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic
14.08.2012Clin Infect Dis 2012; 55:1408-16
Wandeler Gilles, Rauch Andri, Furrer Hansjakob, Bernasconi Enos, Stöckle Marcel, Calmy Alexandra, Clerc Olivier, Günthard Huldrych F, Bregenzer Andrea, Gsponer Thomas, Swiss HIV Cohort Study
Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes
Elzi L, Battegay M, Weber R, Bernasconi E, Vernazza P, Hirschel B, Cavassini M, Ledergerber B, Furrer H, Erb S, for the Swiss HIV Cohort Study. Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes. Arch Intern Med 2012:1-9.
13.08.2012Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes
13.08.2012Arch Intern Med 2012:1-9
Elzi Luigia, Battegay Manuel, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Hirschel Bernard, Cavassini Matthias, Ledergerber Bruno, Furrer Hansjakob, Erb Stefan, for the Swiss HIV Cohort Study
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
Dusemund F, Carre E, Schuetz P, Gaillat J, Regez K, Bossart R, Schild U, Müller B, Albrich W, Hausfater P, Amin D, Schwietert M, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, ProREAL Study Team. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance. Eur J Clin Microbiol Infect Dis 2012; 32:51-60.
12.08.2012Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance
12.08.2012Eur J Clin Microbiol Infect Dis 2012; 32:51-60
Dusemund F, Carre E, Schuetz P, Gaillat J, Regez K, Bossart R, Schild U, Müller B, Albrich Werner, Hausfater P, Amin D, Schwietert M, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, ProREAL Study Team
How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients
Elzi L, Babouee Flury B, Vögeli N, Laffer R, Dangel M, Frei R, Battegay M, Widmer A. How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients. Clin Microbiol Infect 2012; 18:E355-61.
12.07.2012How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci: a prospective study with 654 patients
12.07.2012Clin Microbiol Infect 2012; 18:E355-61
Elzi L, Babouee Flury Baharak, Vögeli N, Laffer R, Dangel M, Frei R, Battegay M, Widmer A F
MRSA decolonization: success rate, risk factors for failure and optimal duration of follow-up
Kohler P, Bregenzer-Witteck A, Rettenmund G, Otterbech S, Schlegel M. MRSA decolonization: success rate, risk factors for failure and optimal duration of follow-up. Infection 2012; 41:33-40.
11.07.2012MRSA decolonization: success rate, risk factors for failure and optimal duration of follow-up
11.07.2012Infection 2012; 41:33-40
Kohler Philipp, Bregenzer-Witteck A, Rettenmund G, Otterbech S, Schlegel Matthias
Perceived HIV symptom manageability: synthesis of a new use for a known concept
Fierz K, Nicca D, Spirig R. Perceived HIV symptom manageability: synthesis of a new use for a known concept. J Adv Nurs 2012; 69:229-41.
06.07.2012Perceived HIV symptom manageability: synthesis of a new use for a known concept
06.07.2012J Adv Nurs 2012; 69:229-41
Fierz Katharina, Nicca Dunja, Spirig Rebecca
[Purulent lymphadenitis after peritonsillar abscess under immunosuppression. An often forgotten differential diagnosis]
Jeleff O, Gutmann C, Greminger P, Binet F, Stöckli S, Broglie Däppen M. [Purulent lymphadenitis after peritonsillar abscess under immunosuppression. An often forgotten differential diagnosis]. HNO 2012; 60:622-5.
01.07.2012[Purulent lymphadenitis after peritonsillar abscess under immunosuppression. An often forgotten differential diagnosis]
01.07.2012HNO 2012; 60:622-5
Jeleff O, Gutmann Christine, Greminger Peter, Binet Françoise-Isabelle, Stöckli Sandro, Broglie Däppen Martina
Transmission of multidrug-resistant Mycobacterium tuberculosis is reality in Switzerland
Niederer-Loher A, Kahlert C, Barben J, Deggim V, Zellweger J. Transmission of multidrug-resistant Mycobacterium tuberculosis is reality in Switzerland. Journal of Pediatric Infectious Diseases 2012:159-160.
25.06.2012Transmission of multidrug-resistant Mycobacterium tuberculosis is reality in Switzerland
25.06.2012Journal of Pediatric Infectious Diseases 2012:159-160
Niederer-Loher Anita, Kahlert Christian, Barben Jürg, Deggim Vanessa, Zellweger Jean-Pierre
Gefährliche Pferdeliebe
Abbassi-Nik A, Gimmi R, Boggian K. Gefährliche Pferdeliebe. Schweiz Med Forum 2012; 12:517-518.
25.06.2012Gefährliche Pferdeliebe
25.06.2012Schweiz Med Forum 2012; 12:517-518
Abbassi-Nik Armin, Gimmi Rolf, Boggian Katia
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
Scherrer A, Günthard H, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Cellerai C, Klimkait T, Yerly S, Böni J, von Wyl V, Ledergerber B, Swiss HIV Cohort Study. Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PloS one 2012; 7:e37983.
18.06.2012Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
18.06.2012PloS one 2012; 7:e37983
Scherrer Alexandra U, Günthard Huldrych F, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Cellerai Cristina, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Ledergerber Bruno, Swiss HIV Cohort Study
Prosthetic valve endocarditis caused by a Pasteurella dagmatis-like isolate originating from a patient's cat
Strahm C, Goldenberger D, Gutmann M, Kuhnert P, Graber P. Prosthetic valve endocarditis caused by a Pasteurella dagmatis-like isolate originating from a patient's cat. J Clin Microbiol 2012; 50:2818-9.
06.06.2012Prosthetic valve endocarditis caused by a Pasteurella dagmatis-like isolate originating from a patient's cat
06.06.2012J Clin Microbiol 2012; 50:2818-9
Strahm Carol, Goldenberger Daniel, Gutmann Marc, Kuhnert Peter, Graber Peter
Incidence and clinical significance of CMV disease in a countywide prospective cohort of solid-organ transplant recipients
Manuel O, Pascual M, Cusini A, Boggian K, Christoph B, Van Delden C, Maja W, Hirsch H, Garzoni C, Müller N, Kralidis G, Meylan P (2012). Incidence and clinical significance of CMV disease in a countywide prospective cohort of solid-organ transplant recipients.
02.06.2012Incidence and clinical significance of CMV disease in a countywide prospective cohort of solid-organ transplant recipients
02.06.2012American Transplant Congress
Manuel Oriol, Pascual Manuel, Cusini Alexia, Boggian Katia, Christoph Berger, Van Delden Christian, Maja Weisser, Hirsch Hans H, Garzoni Christian, Müller Nicolas J, Kralidis Georg, Meylan Pascal
Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort Study
Bucher H, Battegay M, Furrer H, Weber R, Hirschel B, Vernazza P, Cavassini M, Wang Q, Magenta L, Glass T, Richter W, Bernasconi E. Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2012; 60:135-42.
01.06.2012Small dense lipoproteins, apolipoprotein B, and risk of coronary events in HIV-infected patients on antiretroviral therapy: the Swiss HIV Cohort Study
01.06.2012J Acquir Immune Defic Syndr 2012; 60:135-42
Bucher Heiner C, Battegay Manuel, Furrer Hansjakob, Weber Rainer, Hirschel Bernard, Vernazza Pietro, Cavassini Matthias, Wang Qing, Magenta Lorenzo, Glass Tracy R, Richter Werner, Bernasconi Enos
Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods
Rodger A, Corbelli G, Van Lunzen J, Estrada V, Collins S, Vernazza P, Weait M, Bruun T, Phillips A, Lundgren J. Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods. BMC Public Health 2012; 12:296.
20.04.2012Partners of people on ART - a New Evaluation of the Risks (The PARTNER study): design and methods
20.04.2012BMC Public Health 2012; 12:296
Rodger Alison, Corbelli Giulio Maria, Van Lunzen Jan, Estrada Vicente, Collins Simon, Vernazza Pietro, Weait Matthew, Bruun Tina, Phillips Andrew, Lundgren Jens
Functional impaired influenza-specific cellular immunity after vaccination in HIV-positive patients with low CD4 nadir despite absolute CD4 cell recovery under cART
Hoffmann M, Penski N, Vernazza P (2012). Functional impaired influenza-specific cellular immunity after vaccination in HIV-positive patients with low CD4 nadir despite absolute CD4 cell recovery under cART.
03.04.2012Functional impaired influenza-specific cellular immunity after vaccination in HIV-positive patients with low CD4 nadir despite absolute CD4 cell recovery under cART
03.04.201222nd ECCMID
Hoffmann Matthias, Penski Nicola, Vernazza Pietro
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes
Fenner L, Egger M, Helbling P, Böttger E, Bodmer T, Schrenzel J, Bernasconi E, Hoffmann M, Cavassini M, Fehr J, Janssens J, Gagneux S, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups. Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes. PloS one 2012; 7:e34186.
30.03.2012Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes
30.03.2012PloS one 2012; 7:e34186
Fenner Lukas, Egger Matthias, Helbling Peter, Böttger Erik C, Bodmer Thomas, Schrenzel Jacques, Bernasconi Enos, Hoffmann Matthias, Cavassini Matthias, Fehr Jan, Janssens Jean-Paul, Gagneux Sebastien, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups